NO2332947T3 - - Google Patents

Info

Publication number: NO2332947T3
Authority: NO; Norway

Application number

NO11155100A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-17

Filing date

2009-07-15

Publication date

2018-03-31

2009-07-15 Application filed filed Critical

2018-03-31 Publication of NO2332947T3 publication Critical patent/NO2332947T3/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/04—Carbocyclic radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Crystallography & Structural Chemistry (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)

NO11155100A 2008-07-17 2009-07-15 NO2332947T3 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8142308P	2008-07-17	2008-07-17
EP09790436.1		2009-07-15

Publications (1)

Publication Number	Publication Date
NO2332947T3 true NO2332947T3 (no)	2018-03-31

Family

ID=41137707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO11155100A NO2332947T3 (no)	2008-07-17	2009-07-15

Country Status (29)

Country	Link
US (2)	US8217156B2 (no)
EP (1)	EP2332947B1 (no)
JP (2)	JP2011528366A (no)
KR (2)	KR101707246B1 (no)
CN (2)	CN102112483A (no)
AR (1)	AR072807A1 (no)
AU (1)	AU2009270973B2 (no)
BR (1)	BRPI0916191A2 (no)
CA (1)	CA2730931A1 (no)
CL (1)	CL2009001595A1 (no)
CO (1)	CO6351797A2 (no)
DK (1)	DK2332947T3 (no)
ES (1)	ES2656357T3 (no)
HK (1)	HK1243713A1 (no)
HU (1)	HUE035400T2 (no)
IL (1)	IL210269A (no)
MX (1)	MX2011000503A (no)
NO (1)	NO2332947T3 (no)
NZ (1)	NZ590184A (no)
PE (1)	PE20100260A1 (no)
PL (1)	PL2332947T3 (no)
PT (1)	PT2332947T (no)
RU (1)	RU2505543C2 (no)
SG (1)	SG185317A1 (no)
TW (1)	TWI472521B (no)
UA (1)	UA106048C2 (no)
UY (1)	UY31992A (no)
WO (1)	WO2010009197A1 (no)
ZA (1)	ZA201100175B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI499414B (zh) *	2006-09-29	2015-09-11	Lexicon Pharmaceuticals Inc	鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ２）的抑制物與其應用方法
WO2009014970A1 (en)	2007-07-26	2009-01-29	Lexicon Pharmaceuticals, Inc.	Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
AU2009270936B2 (en)	2008-07-15	2014-12-18	Theracos, Inc.	Deuterated benzylbenzene derivatives and methods of use
TWI472521B (zh)	2008-07-17	2015-02-11	Lexicon Pharmaceuticals Inc	（２ｓ，３ｒ，４ｒ，５ｓ，６ｒ）－２－（４－氯－３－（４－乙氧苄基）苯基）－６－（甲硫）四氫－２ｈ－哌喃－３，４，５－三醇的固體形態與其使用方法
TWI562775B (en) *	2010-03-02	2016-12-21	Lexicon Pharmaceuticals Inc	Methods of using inhibitors of sodium-glucose cotransporters 1 and 2
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
CN102453026A (zh)	2010-10-27	2012-05-16	上海艾力斯医药科技有限公司	C-芳基葡糖苷衍生物、制备方法及其应用
TWI631963B (zh) *	2011-01-05	2018-08-11	雷西肯製藥股份有限公司	包含鈉－葡萄糖共同輸送體１與２之抑制劑的組合物與應用方法
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en)	2011-09-27	2013-04-04	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
SG11201503923XA (en)	2012-11-20	2015-06-29	Lexicon Pharmaceuticals Inc	Inhibitors of sodium glucose cotransporter 1
WO2015058084A1 (en)	2013-10-18	2015-04-23	Medivation Technologies, Inc.	Heterocyclic compounds and methods of use
WO2015069441A1 (en)	2013-10-18	2015-05-14	Medivation Technologies, Inc.	Pyrazolo-, imidazolo- and pyrrolo-pyridine or -pyrimidine derivatives as inhibitors o brutons kinase (btk)
MY186959A (en)	2015-07-30	2021-08-26	Microbial Chem Res Found	New effective aminoglycoside antibiotic for multidrug-resistant bacteria
EP3466958B1 (en) *	2016-05-25	2020-04-29	Crystal Pharmaceutical (Suzhou) Co., Ltd.	New crystal forms of sodium-glucose co-transporter inhibitor, processes for preparation and use thereof
WO2018067805A1 (en)	2016-10-06	2018-04-12	Teva Pharmaceutical Industries Ltd.	Solid state forms of sotagliflozin
AU2017344882A1 (en)	2016-10-19	2019-03-28	Boehringer Ingelheim International Gmbh	Combinations comprising an SSAO/VAP-1 inhibitor and a SGLT2 inhibitor, uses thereof
WO2019201752A1 (en)	2018-04-17	2019-10-24	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
CN110818722B (zh) *	2018-08-14	2022-12-02	苏州鹏旭医药科技有限公司	三种化合物及其制备方法和在合成索格列净中的用途
WO2020068661A1 (en) *	2018-09-26	2020-04-02	Lexicon Pharmaceuticals, Inc.	Crystalline forms of n-(1 -((2-(dimethylamino)ethyl)amino)-2-m ethyl-1 -oopropan-2-yl)-4-(4-(2-methyl-5- (2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2h-pyran-2-yl)benzyl) phenl)butanamide and methods of their synthesis
CN109824687B (zh) *	2019-03-26	2022-03-22	上海凌凯医药科技有限公司	呋喃木糖衍生物的新合成方法
US20220324897A1 (en) *	2019-07-05	2022-10-13	Shandong Danhong Pharmaceutical Co., Ltd.	Crystal form of sglt inhibitor and application thereof
EP3771480A1 (en) *	2019-08-01	2021-02-03	Lexicon Pharmaceuticals, Inc.	Continuous process for preparing the crystalline form ii of sotagliflozin
EP3771718A1 (en)	2019-08-01	2021-02-03	Lexicon Pharmaceuticals, Inc.	Process for preparing the crystalline form ii of sotagliflozin
WO2022144465A1 (en)	2021-01-04	2022-07-07	Charité-Universitätsmedizin Berlin	Sotagliflozin for improving left atrial function
US20220370485A1 (en)	2021-01-14	2022-11-24	Lexicon Pharmaceuticals, Inc.	Compounds and methods for treating or preventing cardiovascular diseases and conditions
CN113880701A (zh) *	2021-10-10	2022-01-04	浙江司太立制药股份有限公司	一种抗糖尿病药物中间体及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3870699A (en) *	1973-03-06	1975-03-11	Upjohn Co	Lincomycin analogs
NZ519984A (en) *	2000-01-07	2004-03-26	Transform Pharmaceuticals Inc	High-throughput formation, identification, and analysis of diverse solid-forms
WO2006018150A1 (de)	2004-08-11	2006-02-23	Boehringer Ingelheim International Gmbh	D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
ES2334940T3 (es)	2005-02-23	2010-03-17	Boehringer Ingelheim International Gmbh	Derivados de ((hetero)ariletinilbencil)benceno sustituidos con glucopiranosilo y uso de los mismos como inhibidores del cotransportador 2 de glucosa dependiente de sodio (sglt2).
CN1820858A (zh) *	2006-03-10	2006-08-23	广西中医学院制药厂	多相物料喷雾方法及装置
TWI499414B (zh) *	2006-09-29	2015-09-11	Lexicon Pharmaceuticals Inc	鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ２）的抑制物與其應用方法
WO2008109591A1 (en) *	2007-03-08	2008-09-12	Lexicon Pharmaceuticals, Inc.	Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
WO2009014970A1 (en) *	2007-07-26	2009-01-29	Lexicon Pharmaceuticals, Inc.	Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
TWI472521B (zh)	2008-07-17	2015-02-11	Lexicon Pharmaceuticals Inc	（２ｓ，３ｒ，４ｒ，５ｓ，６ｒ）－２－（４－氯－３－（４－乙氧苄基）苯基）－６－（甲硫）四氫－２ｈ－哌喃－３，４，５－三醇的固體形態與其使用方法

2009
- 2009-07-01 TW TW98122274A patent/TWI472521B/zh active
- 2009-07-15 SG SG2012077681A patent/SG185317A1/en unknown
- 2009-07-15 JP JP2011518868A patent/JP2011528366A/ja active Pending
- 2009-07-15 PT PT111551008T patent/PT2332947T/pt unknown
- 2009-07-15 UA UAA201101832A patent/UA106048C2/uk unknown
- 2009-07-15 BR BRPI0916191A patent/BRPI0916191A2/pt not_active Application Discontinuation
- 2009-07-15 MX MX2011000503A patent/MX2011000503A/es active IP Right Grant
- 2009-07-15 EP EP11155100.8A patent/EP2332947B1/en active Active
- 2009-07-15 DK DK11155100.8T patent/DK2332947T3/da active
- 2009-07-15 AR ARP090102685A patent/AR072807A1/es unknown
- 2009-07-15 US US12/503,225 patent/US8217156B2/en active Active
- 2009-07-15 NO NO11155100A patent/NO2332947T3/no unknown
- 2009-07-15 CN CN2009801279245A patent/CN102112483A/zh active Pending
- 2009-07-15 NZ NZ590184A patent/NZ590184A/xx unknown
- 2009-07-15 RU RU2011105797/04A patent/RU2505543C2/ru active
- 2009-07-15 PL PL11155100T patent/PL2332947T3/pl unknown
- 2009-07-15 PE PE2009000944A patent/PE20100260A1/es not_active Application Discontinuation
- 2009-07-15 CA CA2730931A patent/CA2730931A1/en not_active Abandoned
- 2009-07-15 HU HUE11155100A patent/HUE035400T2/en unknown
- 2009-07-15 AU AU2009270973A patent/AU2009270973B2/en active Active
- 2009-07-15 ES ES11155100.8T patent/ES2656357T3/es active Active
- 2009-07-15 KR KR1020117001024A patent/KR101707246B1/ko active IP Right Grant
- 2009-07-15 CL CL2009001595A patent/CL2009001595A1/es unknown
- 2009-07-15 KR KR1020177001061A patent/KR20170010069A/ko not_active Application Discontinuation
- 2009-07-15 CN CN201710477527.7A patent/CN107629097A/zh not_active Withdrawn
- 2009-07-15 WO PCT/US2009/050636 patent/WO2010009197A1/en active Application Filing
- 2009-07-16 UY UY0001031992A patent/UY31992A/es not_active Application Discontinuation
2010
- 2010-12-26 IL IL210269A patent/IL210269A/en active IP Right Grant
2011
- 2011-01-06 ZA ZA2011/00175A patent/ZA201100175B/en unknown
- 2011-02-09 CO CO11014849A patent/CO6351797A2/es not_active Application Discontinuation
2012
- 2012-06-22 US US13/530,645 patent/US9067962B2/en active Active
2015
- 2015-09-30 JP JP2015193990A patent/JP6283337B2/ja active Active
2018
- 2018-03-02 HK HK18103068.1A patent/HK1243713A1/zh unknown

Also Published As

Publication number	Publication date
CL2009001595A1 (es)	2010-07-19
CA2730931A1 (en)	2010-01-21
WO2010009197A1 (en)	2010-01-21
TWI472521B (zh)	2015-02-11
AU2009270973A1 (en)	2010-01-21
EP2332947A1 (en)	2011-06-15
JP2011528366A (ja)	2011-11-17
KR20170010069A (ko)	2017-01-25
US9067962B2 (en)	2015-06-30
KR20110031196A (ko)	2011-03-24
JP2016041701A (ja)	2016-03-31
HK1243713A1 (zh)	2018-07-20
IL210269A0 (en)	2011-03-31
NZ590184A (en)	2012-09-28
AR072807A1 (es)	2010-09-22
PE20100260A1 (es)	2010-04-16
MX2011000503A (es)	2011-03-01
CN107629097A (zh)	2018-01-26
EP2332947B1 (en)	2017-11-01
TW201006808A (en)	2010-02-16
US20130165395A1 (en)	2013-06-27
DK2332947T3 (da)	2018-01-29
BRPI0916191A2 (pt)	2017-08-29
RU2505543C2 (ru)	2014-01-27
ZA201100175B (en)	2012-03-28
US8217156B2 (en)	2012-07-10
ES2656357T3 (es)	2018-02-26
PT2332947T (pt)	2018-02-06
UY31992A (es)	2010-02-26
CN102112483A (zh)	2011-06-29
KR101707246B1 (ko)	2017-02-15
JP6283337B2 (ja)	2018-02-21
SG185317A1 (en)	2012-11-29
PL2332947T3 (pl)	2018-04-30
IL210269A (en)	2015-06-30
AU2009270973B2 (en)	2014-01-30
CO6351797A2 (es)	2011-12-20
UA106048C2 (uk)	2014-07-25
RU2011105797A (ru)	2012-08-27
HUE035400T2 (en)	2018-05-02
US20100016422A1 (en)	2010-01-21

Publication	Publication Date	Title
BR112016019572A2 (no)	2017-08-15
BRPI0909040A2 (no)	2017-09-19
BRPI0917573A2 (no)	2017-07-11
BRPI0908549B8 (no)	2021-06-08
BRPI0918697A2 (no)	2017-08-29
BRPI0917525A2 (no)	2017-07-04
BRPI0920750A2 (no)	2016-02-02
BRPI0919470A2 (no)	2017-08-22
BRPI0922455A2 (no)	2021-12-28
BRPI0917618A8 (no)	2019-09-10
BRPI0907698A2 (no)	2017-08-22
BRPI0923734A2 (no)	2017-07-11
BRPI0912727A2 (no)	2017-08-29
BRPI0908285A2 (no)	2017-08-29
BRPI0910485A2 (no)	2017-08-29
BRPI0914750A2 (no)	2017-08-15
BRPI0922669A2 (no)	2017-07-11
BRPI0908120A2 (no)	2017-08-22
BRPI0912462A2 (no)	2016-02-02
BRPI0915616A2 (no)	2016-02-02
BRPI0904541A8 (no)	2010-09-21
BRPI0919811A2 (no)	2017-08-29
BRPI0920914A2 (no)	2017-07-11
BRPI0922550A2 (no)	2016-02-02
BRPI0916284A2 (no)	2017-08-08